Cargando…

Effect of Shexiang Tongxin dropping pill on stable coronary artery disease patients with normal fractional flow reserve and coronary microvascular disease: A study protocol

INTRODUCTION: Coronary microvascular disease (CMVD) can affect the structure, function, and metabolism of the heart, and has an important impact on the occurrence, development and prognosis of coronary artery disease (CAD). Shexiang Tongxin dropping pill (STDP) can dilate blood vessels, alleviate in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yanli, Chu, Xiaopeng, Zhang, Jiefang, Zhao, Yanbo, Jin, Chongying, Zhu, Junhui, Fu, Guosheng, Qiu, Fuyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505333/ https://www.ncbi.nlm.nih.gov/pubmed/32957332 http://dx.doi.org/10.1097/MD.0000000000022126

Ejemplares similares

The effect of Shexiang Tongxin Dropping Pills on coronary microvascular dysfunction (CMVD) among those with a mental disorder and non-obstructive coronary artery disease based on stress cardiac magnetic resonance images: A study protocol
por: Tian, Jinfan, et al.
Publicado: (2020)

Efficacy of Shexiang Tongxin Dropping Pills in a Swine Model of Coronary Slow Flow
por: Bai, Yupeng, et al.
Publicado: (2022)

Shexiang Tongxin Dropping Pill Improves Peripheral Microvascular Blood Flow via Cystathionine-γ-Lyase
por: Zhang, Yanda, et al.
Publicado: (2019)

Exploring the mechanism of Shexiang Tongxin dropping pill in the treatment of microvascular angina through network pharmacology and molecular docking
por: Chang, Chen, et al.
Publicado: (2022)

Shexiang Tongxin dropping pill protects against isoproterenol-induced myocardial ischemia in vivo and in vitro
por: Qi, Jianyong, et al.
Publicado: (2017)

Protective effects of Shexiang Tongxin Dropping Pill on pituitrin-induced acute myocardial ischemia in rats
por: Lin, Shan, et al.
Publicado: (2017)

Shexiang Tongxin Dropping Pills Promote Macrophage Polarization-Induced Angiogenesis Against Coronary Microvascular Dysfunction via PI3K/Akt/mTORC1 Pathway
por: Lu, Xiangyu, et al.
Publicado: (2022)

Shexiang Tongxin Dropping Pill Protects Against Chronic Heart Failure in Mice via Inhibiting the ERK/MAPK and TGF-β Signaling Pathways
por: Zhang, Shuying, et al.
Publicado: (2021)

Qualitative and Quantitative Analysis of the Major Constituents in Shexiang Tongxin Dropping Pill by HPLC-Q-TOF-MS/MS and UPLC-QqQ-MS/MS
por: Chen, Daxin, et al.
Publicado: (2015)

Exploring the active ingredients and mechanism of Shenzhi Tongxin capsule against microvascular angina based on network pharmacology and molecular docking
por: Xuan, Xiaoyu, et al.
Publicado: (2023)

Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Lv, Lina, et al.
Publicado: (2022)

Effects of Shexiang Baoxin Pill for Coronary Microvascular Function: A Systematic Review and Meta-Analysis
por: Wang, Mengxi, et al.
Publicado: (2021)

Efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction: A single-center, double-blind, randomized controlled trial
por: Yang, Yan, et al.
Publicado: (2021)

Effect of Musk Tongxin Dropping Pill on Myocardial Remodeling and Microcirculation Dysfunction in Diabetic Cardiomyopathy
por: Zhao, Jingjing, et al.
Publicado: (2021)

Effects of Shenxiang Suhe Pill on coronary heart disease complicated with nonalcoholic fatty liver disease: A case–control study
por: Ni, Jie, et al.
Publicado: (2022)

Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism
por: Zhang, Ke-Jian, et al.
Publicado: (2017)

Should fraction flow reserve be considered an important decision-making tool to stratify patients with stable coronary artery disease for percutaneous coronary intervention?: A meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow
por: Guo, Hongxin, et al.
Publicado: (2022)

Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
por: Wei, Jingjing, et al.
Publicado: (2021)

Musk Tongxin Dripping Pills for treating Ticagrelor in Patients After Percutaneous Coronary Intervention: Echocardiography Combined with Untargeted Metabolomics
por: Nan, Lyu, et al.
Publicado: (2021)

The effect of early dual antiplatelet timing on the microvascular resistance and ventricular function in primary percutaneous coronary intervention
por: Firman, Doni, et al.
Publicado: (2020)

Giant right coronary artery aneurysms presenting as a cardiac mass: Case report
por: Wang, Huanhuan, et al.
Publicado: (2016)

The Prognosis of Patients With Nonobstructive Coronary Artery Disease Versus Normal Arteries Determined by Invasive Coronary Angiography or Computed Tomography Coronary Angiography: A Systematic Review
por: Huang, Fang-Yang, et al.
Publicado: (2016)

Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Liu, Shengxiang, et al.
Publicado: (2021)

Predictive value of inflammatory factors on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Chu, Xin, et al.
Publicado: (2021)

A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Li, Yachao, et al.
Publicado: (2023)

Predictive value of miRNA-21 on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Dai, Haiyue, et al.
Publicado: (2021)

Validation of Scoring Systems That Predict Outcomes in Patients With Coronary Artery Disease Undergoing Coronary Artery Bypass Grafting Surgery
por: Chung, Wen-Jung, et al.
Publicado: (2015)

Prognostic Significance of Central Pulse Pressure for Mortality in Patients With Coronary Artery Disease Receiving Repeated Percutaneous Coronary Intervention
por: Lin, Mao-Jen, et al.
Publicado: (2016)

Modification of the association between smoking status and severity of coronary stenosis by vitamin D in patients suspected of coronary heart disease
por: Li, Kuibao, et al.
Publicado: (2016)

Influence of hypercholesterolemia and diabetes on long-term outcome in patients with stable coronary artery disease receiving percutaneous coronary intervention
por: Lin, Mao-Jen, et al.
Publicado: (2019)

Plasma interleukin-27 levels in patients with coronary artery disease
por: Miura, Kotaro, et al.
Publicado: (2017)

Circulating microRNAs as biomarkers for severe coronary artery disease
por: Zhang, Xuelin, et al.
Publicado: (2020)

Management of acute coronary syndrome in the context of coronavirus disease 2019
por: Liang, Xi-Ying, et al.
Publicado: (2021)

Percutaneous coronary intervention versus cardiac bypass surgery for left main coronary artery disease: A trial sequential analysis
por: Ye, Yicong, et al.
Publicado: (2017)

Arginine methylation dysfunction increased risk of acute coronary syndrome in coronary artery disease population: A case-control study
por: Zhang, Shengyu, et al.
Publicado: (2017)

Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study
por: Zhang, Juan, et al.
Publicado: (2022)

Optical coherence tomography and fractional flow reserve guided treatment of woven coronary artery anomaly presenting as acute myocardial infarction: A case report
por: Wang, Fangfang, et al.
Publicado: (2020)

Role of Trimetazidine in Ischemic Preconditioning in Patients With Symptomatic Coronary Artery Disease
por: Costa, Leandro M.A., et al.
Publicado: (2015)

Myeloperoxidase polymorphism and coronary artery disease risk: A meta-analysis
por: Wang, Yan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ka0theibi033336fn3eg0dmehm